Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

28.35
+0.98003.58%
Post-market: 28.350.00000.00%19:47 EDT
Volume:1.58M
Turnover:44.41M
Market Cap:4.53B
PE:-68.93
High:28.41
Open:27.59
Low:27.31
Close:27.37
52wk High:29.96
52wk Low:12.00
Shares:159.76M
Float Shares:125.00M
Volume Ratio:0.55
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4113
EPS(LYR):-0.3922
ROE:-38.76%
ROA:-4.12%
PB:31.69
PE(LYR):-72.29

Loading ...

Adaptive Biotechnologies - Prices $300 Mln 0% Convertible Senior Notes Due 2031

THOMSON REUTERS
·
Jun 17

Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering

GlobeNewswire
·
Jun 17

MRD Spinoff And $250 Million Convertible Notes Could Be A Game Changer For Adaptive Biotechnologies (ADPT)

Simply Wall St.
·
Jun 17

Analysts Are Bullish on Top Healthcare Stocks: Pasithea Therapeutics Corp (KTTA), Adaptive Biotechnologies (ADPT)

TIPRANKS
·
Jun 16

Adaptive Biotechnologies offers to sell $250M in 2031 convertible senior notes

TIPRANKS
·
Jun 16

Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky disposes of 5,000 common shares for $95,000

Reuters
·
Jun 16

Stocks to Watch: Dave & Buster's, Adaptive Biotechnologies, Domo, Apollo Commercial Real Estate Finance

Dow Jones
·
Jun 16

BRIEF-Adaptive Biotechnologies Announces Proposed Convertible Senior Notes Offering

Reuters
·
Jun 16

Adaptive Biotechnologies Evaluates Strategic Alternatives for Immune Medicine Business

Dow Jones
·
Jun 16

Adaptive Biotechnologies Weighs Separation of Immune Medicine Unit; Shares Fall After Hours

MT Newswires Live
·
Jun 16

BUZZ-Adaptive Biotechnologies falls after announcing convertible, separation of businesses

Reuters
·
Jun 16

Adaptive to plans to separate minimal residual disease, immune medicine segments

TIPRANKS
·
Jun 16

Adaptive Biotechnologies plans separation of MRD, Immune Medicine units

Reuters
·
Jun 16

Adaptive Biotechnologies - Expects to Identify Immune Medicine Separation Path by Year-End 2026

THOMSON REUTERS
·
Jun 16

Adaptive Biotechnologies Announces Plan to Separate Its Mrd and Immune Medicine Businesses

THOMSON REUTERS
·
Jun 16

Adaptive Biotechnologies plans USD 250 million convertible senior notes offering due 2031

Reuters
·
Jun 16

Adaptive Biotechnologies - to Offer $250 Mln Convertible Senior Notes Due 2031

THOMSON REUTERS
·
Jun 16

Adaptive Biotechnologies - Proceeds to Fund Capped Call and Repurchase up to $25 Mln Common Stock

THOMSON REUTERS
·
Jun 16

Adaptive Biotechnologies - Proceeds Expected to Repay Orbimed Purchase Agreement

THOMSON REUTERS
·
Jun 16

Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering

GlobeNewswire
·
Jun 16